A little more stock available on the sell side - not a bad thing as some volume in trades would be good.
By the companies own presentations the last dose of drug in current trial should be done about now .
Positive that no adverse reactions seem to have occurred ( company may have had to release news if so )
I wouldn’t imagine it would take too long for findings to be reported to market
IXC chart, page-8
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.012M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28219 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 2202 | 1 |
View Market Depth
| Last trade - 10.05am 03/05/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable